These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 3901250)
1. [Physiology and pathology of the entero-insular axis]. Creutzfeldt W Schweiz Med Wochenschr; 1985 Jul; 115(29):970-3. PubMed ID: 3901250 [TBL] [Abstract][Full Text] [Related]
2. Disturbances of the entero-insular axis. Creutzfeldt W; Ebert R; Nauck M; Stöckmann F Scand J Gastroenterol Suppl; 1983; 82():111-9. PubMed ID: 6356314 [TBL] [Abstract][Full Text] [Related]
3. New developments in the incretin concept. Creutzfeldt W; Ebert R Diabetologia; 1985 Aug; 28(8):565-73. PubMed ID: 3902545 [TBL] [Abstract][Full Text] [Related]
4. Entero-insular axis and diabetes mellitus. Creutzfeldt W Horm Metab Res Suppl; 1992; 26():13-8. PubMed ID: 1490680 [TBL] [Abstract][Full Text] [Related]
5. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes. Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793 [TBL] [Abstract][Full Text] [Related]
6. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Miyawaki K; Yamada Y; Yano H; Niwa H; Ban N; Ihara Y; Kubota A; Fujimoto S; Kajikawa M; Kuroe A; Tsuda K; Hashimoto H; Yamashita T; Jomori T; Tashiro F; Miyazaki J; Seino Y Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14843-7. PubMed ID: 10611300 [TBL] [Abstract][Full Text] [Related]
8. Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats. Ebert R; Illmer K; Creutzfeldt W Gastroenterology; 1979 Mar; 76(3):515-23. PubMed ID: 34554 [TBL] [Abstract][Full Text] [Related]
9. [The entero-insular axis]. Yu JR Sheng Li Ke Xue Jin Zhan; 1984 Jan; 15(1):83-6. PubMed ID: 6393335 [No Abstract] [Full Text] [Related]
10. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents. Creutzfeldt W Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578 [TBL] [Abstract][Full Text] [Related]
11. The ageing entero-insular axis. Ranganath L; Sedgwick I; Morgan L; Wright J; Marks V Diabetologia; 1998 Nov; 41(11):1309-13. PubMed ID: 9833938 [TBL] [Abstract][Full Text] [Related]
12. [Effect of incretin hormones GIP and GLP-1 for the pathogenesis of type 2 diabetes mellitus]. Vilsbøll T; Knop FK Ugeskr Laeger; 2007 May; 169(22):2101-5. PubMed ID: 17553392 [TBL] [Abstract][Full Text] [Related]
19. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877 [TBL] [Abstract][Full Text] [Related]
20. Physiology of GIP--a lesson from GIP receptor knockout mice. Yamada Y; Seino Y Horm Metab Res; 2004; 36(11-12):771-4. PubMed ID: 15655707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]